在瘤微环境中细菌的殖民化为免疫性化疗创造了有利的利基
See-Khai Lim1, Wen-Ching Lin1, Sin-Wei Huang1
1Institute of Biomedical Sciences, Academia Sinica, Taipei, 11529, Taiwan.
EMBO molecular medicine
|January 15, 2024
概括
引入免疫性化疗的细菌,如氧沙,有效地打击瘤微环境 (TME). 这种组合消除了瘤,并在小鼠中建立了持久的抗瘤免疫力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 瘤微环境 (TME) 施加差异选择性压力 (DSP),有利于癌细胞生长,通常压倒单价疗法.
- 目前的治疗方法在免疫抑制TME中努力扭转癌细胞的主导地位.
研究的目的:
- 探索使用细菌改变DSP用于瘤根除的组合治疗策略.
- 研究细菌与不同化疗剂对抗瘤免疫力的协同作用.
主要方法:
- 将细菌作为外来物种引入TME.
- 服用选择性化疗药物 (oxaliplatin,5-FU) 和禁食与细菌结合使用.
- 评估小鼠的瘤生长,免疫激活 (先天性和适应性) 和免疫记忆.
主要成果:
- 癌症选择性化疗和与细菌相结合的禁食,对瘤生长产生了强大的选择压力.
- 奥克萨利普拉丁是一种免疫药物,与细菌协同激活先天性和适应性免疫力,从而导致完全的瘤缓解和持续的抗瘤免疫记忆.
- 牛氧-细菌组合显著增强了抗原呈现细胞上的共刺激和抗原呈现分子,促进了细胞毒性T细胞介导的癌细胞杀死.
结论:
- 细菌疗法和免疫性化疗的合理组合可以克服免疫抑制性TME.
- 这种组合方法促进了强大的抗癌免疫力,为瘤根除提供了有前途的策略.
更多相关视频
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Vaccines
368
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
368


